New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that selective serotonin reuptake inhibitor (SSRI) treatment for postnatal depression is associated with ...
Aug 29, 2023
0
8
Researchers from the Centre for Gene Therapy & Regenerative Medicine at King's College London, in collaboration with colleagues from University College London, have developed the first truly scalable human iPSC-neuromuscular ...
Aug 29, 2023
0
6
A new analysis in the BMJ argues that UK government opposition to drug consumption rooms is rooted in societal stigma
Aug 22, 2023
0
6
Research and development (R&D) costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not be reflected in ...
Aug 21, 2023
0
1
A team of King's Informatics researchers have developed a series of prototype tools that empower communities with communication impairments to speak up. Co-designed with focus groups of complex communication needs (CCNs) ...
Aug 18, 2023
0
2
New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants
Aug 10, 2023
0
5
Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London have used a novel approach to show that the patterns of activity in two brain chemical systems—glutamate and serotonin—are ...
Aug 9, 2023
0
171
New research from The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has successfully reversed hearing loss in mice.
Aug 9, 2023
0
68
A machine commonly used for pain relief has shown to improve breathing in patients with obstructive sleep apnea, a clinical trial has found.
Aug 3, 2023
0
23
New research has found irregular sleep patterns are associated with harmful bacteria in your gut.
Aug 1, 2023
0
24
